Bioactive Protein and Peptides Market Size is valued at 65.40 Bn in 2024 and is predicted to reach 166.94 Billion by the year 2034 at a 9.9 % CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Bioactive peptides are a mixture of amino acids bound together by a covalent link and are derived from numerous natural sources, offering a range of health advantages. The rising body of research on natural components can assist soothe worries in the market, similar to many other industries, by providing diverse functions for food and beverage items that result in less oxidation and deterioration.
Additionally, proteins derived from animal parts were being used as cosmetic ingredients. Sectors, including cosmetics, food, and beverage, are also embracing natural trends to project a positive image in the market. As a result, the market growth will be accelerated during the projection period by increasing the use of bioactive proteins and peptides in cosmetic and personal care products. The market for bioactive peptides is anticipated to expand rapidly. Bioactive proteins, which are increasingly essential to consumers due to a rise in demand for nutritious meals, are found in the global bioactive protein and peptides.
On the one hand, purchasing natural foods made from raw materials becomes very expensive. Conversely, since chronic illnesses and lifestyle illnesses like diabetes are rising, trends like going to the gym and exercising are becoming more popular. As a result, keeping up with these developments, it is anticipated that the worldwide bioactive protein and peptides will soon be able to meet the affordable yet significant demand for protein.
The bioactive protein and peptides market is segmented on the Source and application, functionality and end-use industry. Based on Source, the market is divided into Animal(Dairy sub-segments(Whey, Casein, Milk Protein Concentrate), Egg & Meat, Gelatin, Fish & Insects, Seafood ), Plant Source (Cereals (Wheat, Corn & Others), Legumes (Soybean, Pea)(Soy Protein Concentrates, Soy Protein Isolates, Textured Soy Protein)), Pseudo cereals, Brasssicaceae species, Others (Sunflower). Based on application, the bioactive protein and peptides market is segmented on application into functional food, functional beverages, dietary supplements, animal nutrition, personal care, and others (printing & painting). By Functionality, the market consists of Antioxidant, Antimicrobial, Antihypertensive, Immunomodulatory, Anti-inflammatory). End-Use Industry segmen comprises Food and Beverage Industry, Nutraceutical Industry, Cosmetic Industry, Pharmaceutical Industry, Animal Feed Industry.
The plant derived segment led the market during the forecast period. Due to rising consumer demand for vegetarian diets, plant-based bioactive protein and peptides from soy and pea are becoming more prominent in the market. Meat avoidance is becoming more popular for various ethical, environmental, and health reasons. Additionally, plant-source bioactive proteins and peptides are often 20% to 30% less expensive than bioactive proteins and peptides derived from animal sources, and manufacturers, therefore, frequently use them due to the simplicity of the extraction procedure.
Animal Nutrition grabbed the highest revenue share, and it is anticipated that it will continue to hold that position during the anticipated time. Animal nutrition focuses on the dietary requirements of animals, primarily those used in agriculture and food production, but also those kept in aquariums, zoos, and for the management of wildlife. Animal nutrition is crucial for the health and productivity of farm animals. The market will have opportunities during the anticipated period due to the feed industry's growing technological advancements. Animal nutrition market growth is primarily driven by rising demand for safe and healthy animal feed, restrictions on antibiotic use, and increased producer awareness of animal health.
The North American bioactive protein and peptides market is expected to register the highest market share. Due to the rising demand for sports and dietary foods, North America's bioactive protein and peptides market is expanding quickly. In North America, consumers are very concerned about their health and wellness equipment. Additionally, consumers in North America are choosing ready-to-eat and ready-to-drink food and beverages due to their busy lifestyles and work cultures. This has created an enormous opportunity for manufacturers in the North American bioactive protein and peptides market to create products specifically for the functional food and beverage segment. Besides, the Asia Pacific region is accounted to hold a significant share of the market. Due to the widespread consumption of animal products and the well-established animal nutrition system. Due to lucrative market opportunities in the animal feed sector, like those offered by Eubiotics, and growing concerns about the disease outbreak in the region, the Asia Pacific market is anticipated to grow significantly over the coming years.
Report Attribute |
Specifications |
Market Size Value In 2024 |
USD 65.40 Billion |
Revenue Forecast In 2034 |
USD 166.94 Billion |
Growth Rate CAGR |
CAGR of 9.9% from 2025 to 2034 |
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2025 to 2034 |
Historic Year |
2021 to 2024 |
Forecast Year |
2025-2034 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
Source, Application, Functionality, End-Use segment |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
Competitive Landscape |
Archer Daniels Midland Company (ADM), Kerry Group, Cargill Inc., Omega Protein Corporation, Bunge Ltd., E.I., Du Pont De Nemours and Company, Fonterra Co-operative Group Ltd., Royal DSM and CHS Inc. |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Bioactive Protein and Peptides Market Snapshot
Chapter 4. Global Bioactive Protein and Peptides Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Bioactive Protein and Peptides Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on BIOACTIVE PROTEIN AND PEPTIDES MARKET Industry Trends
Chapter 5. Bioactive Protein and Peptides Market Segmentation 1: By Source, Estimates & Trend Analysis
5.1. Market Share by Source, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source:
5.2.1. Animal Derived
5.2.1.1. Dairy
5.2.1.1.1. Whey
5.2.1.1.2. Casein
5.2.1.1.3. Milk Protein Concentrate
5.2.1.2. Egg & Meat
5.2.1.3. Gelatin
5.2.1.4. Fish & Insects
5.2.1.5. Seafood
5.2.2. Plant Derived
5.2.2.1. Cereals (Wheat, Corn & Others)
5.2.2.2. Legumes (Soybean, Pea)
5.2.2.2.1. Soy protein Concentrates
5.2.2.2.2. Soy Protein Isolates
5.2.2.2.3. Textured Soy Protein
5.2.2.3. Pseudo cereals
5.2.2.4. Brasssicaceae species
5.2.2.5. Others (Sunflower, Hemp)
Chapter 6. Bioactive Protein and Peptides Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Food and Beverages
6.2.2. Nutritional Supplements
6.2.3. Cosmetics and Personal Care
6.2.4. Pharmaceuticals
6.2.5. Animal Feed
Chapter 7. Bioactive Protein and Peptides Market Segmentation 3: By Functionality, Estimates & Trend Analysis
7.1. Market Share by Functionality, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Functionality:
7.2.1. Antioxidant
7.2.2. Antimicrobial
7.2.3. Antihypertensive
7.2.4. Immunomodulatory
7.2.5. Anti-inflammatory
Chapter 8. Bioactive Protein and Peptides Market Segmentation 4: By End-Use Industry, Estimates & Trend Analysis
8.1. Market Share by End-Use Industry, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-Use Industry:
8.2.1. Food and Beverage Industry
8.2.2. Nutraceutical Industry
8.2.3. Cosmetic Industry
8.2.4. Pharmaceutical Industry
8.2.5. Animal Feed Industry
Chapter 9. Bioactive Protein and Peptides Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Bioactive Protein and Peptides Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.2.3. North America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. North America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Functionality, 2021-2034
9.2.5. North America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by End-Use Industry, 2021-2034
9.3. Europe
9.3.1. Europe Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.3.3. Europe Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Europe Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Functionality, 2021-2034
9.3.5. Europe Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by End-Use Industry, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. South Korea
9.4.1.5. Southeast Asia
9.4.1.6. Rest of Asia Pacific
9.4.2. Asia Pacific Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.4.3. Asia Pacific Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Asia Pacific Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts By Functionality, 2021-2034
9.4.5. Asia Pacific Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by End-Use Industry, 2021-2034
9.5. Latin America
9.5.1. Latin America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Argentina
9.5.1.4. Rest of Latin America
9.5.2. Latin America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.5.3. Latin America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Latin America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Functionality, 2021-2034
9.5.5. Latin America Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by End-Use Industry, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. South Africa
9.6.1.3. Rest of Middle East and Africa
9.6.2. Middle East & Africa Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.6.3. Middle East & Africa Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.4. Middle East & Africa Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Functionality, 2021-2034
9.6.5. Middle East & Africa Bioactive Protein and Peptides Market Revenue (US$ Million) Estimates and Forecasts by End-Use Industry, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Archer Daniels
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Midland Company (ADM),
10.2.3. Kerry Group,
10.2.4. Cargill Inc.,
10.2.5. Omega Protein Corporation,
10.2.6. Bunge Ltd., E.I.,
10.2.7. Du Pont De Nemours and Company,
10.2.8. Fonterra Co-operative Group Ltd.,
10.2.9. Royal DSM
10.2.10. CHS Inc.
10.2.11. Other Market Players
Bioactive Protein and Peptides Market By Source:
Bioactive Protein and Peptides Market By Application:
Bioactive Protein and Peptides Market By Functionality
End-Use Industry
Bioactive Protein and Peptides Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.